Access to yellow fever travel vaccination centres in England, Wales, and Northern Ireland: A geographical study

Petersen, Jakob; Simons, Hilary; Patel, Dipti

doi:10.1016/j.tmaid.2017.07.002

Cited by 6 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even routine forms of vaccination-such as the annual winter flu programme, or vaccinations predominantly offered to travelers-are notably absent from studies of health service accessibility, with the only known example related to accessibility of Yellow Fever vaccination sites [10]. Studies specifically related to vaccination site accessibility may be limited because those vaccines are typically administered via existing health facilities such as GP surgeries, for which a series of accessibility metrics do exist [11].…”

Section: Introductionmentioning

confidence: 99%

Evaluating the Geographical Accessibility and Equity of COVID-19 Vaccination Sites in England

Duffy

Newing

Górska³

2021

Vaccines

View full text Add to dashboard Cite

We assess the geographical accessibility of COVID-19 vaccination sites—including mass vaccination centers and community-level provision—in England utilizing open data from NHS England and detailed routing data from HERE Technologies. We aim to uncover inequity in vaccination site accessibility, highlighting small-area inequality hidden by coverage figures released by the NHS. Vaccination site accessibility measures are constructed at a neighborhood level using indicators of journey time by private and public transport. We identify inequity in vaccination-site accessibility at the neighborhood level, driven by region of residence, mode of transport (specifically availability of private transport), rural-urban geography and the availability of GP-led services. We find little evidence that accessibility to COVID-19 vaccination sites is related to underlying area-based deprivation. We highlight the importance of GP-led provision in maintaining access to vaccination services at a local level and reflect on this in the context of phase 3 of the COVID-19 vaccination programme (booster jabs) and other mass vaccination programmes.

show abstract

Section: Introductionmentioning

confidence: 99%